Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: J Matern Fetal Neonatal Med. 2012 Nov 23;26(4):327–338. doi: 10.3109/14767058.2012.735724

Figure 5. IL-33 and IL1RL1 (ST2) mRNA expression in HUVECs.

Figure 5

(A) HUVECs treated with IL-1β expressed significantly increased IL-33 mRNA at a concentration of 1 ng/ml (p=0.02) and a slight increase at 10 ng/ml although this difference was not significant (p=0.11). IL1RL1 (ST2) mRNA expression significantly increased with IL-1β treatment (p=0.001 for 1 ng/ml and p=0.003 for 10 ng/ml. (B) IL-33 and IL1RL1 (ST2) mRNA expression did not change in HUVECs treated with CXCL10.